Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roch Houot

Showing results (31-40 of 233) with videos related to

Pageof 24
Sort By:
Trends in Immunology|September 13, 2011
Targeting immune effector cells to promote antibody-induced cytotoxicity in cancer immunotherapyRoch Houot, Holbrook E Kohrt, Aurélien Marabelle, et al.
Current Opinion in Immunology|January 11, 2015
Dual antibody therapy to harness the innate anti-tumor immune response to enhance antibody targeting of tumorsCariad Chester, Aurelien Marabelle, Roch Houot, et al.
Cancer Journal (Sudbury, Mass.)|June 5, 2020
Immune and Cell Therapy in Non-Hodgkin LymphomaReid W Merryman, Roch Houot, Philippe Armand, et al.
Hemasphere|May 1, 2026
In vivo CAR therapies: Turning the patient into their own CAR factoryFrançois Vilcot, Carole-Anne Brugère, Jaime Fuentealba, et al.
Dermatology (Basel, Switzerland)|October 13, 2006
Aggressive CD30 large cell lymphoma after cyclosporine given for putative atopic dermatitisFanny Mougel, Stéphane Dalle, Brigitte Balme, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2024
Cancer immunotherapy in elderly patients: The concept of immune senescence challenged by clinical experienceMathilde Guégan, Malvina Bichon, Nathalie Chaput, et al.
European Journal of Cancer (Oxford, England : 1990)|September 27, 2022
Transplant-ineligible but chimeric antigen receptor T-cells eligible: a real and relevant populationSamuel Vic, Jean Lemoine, Philippe Armand, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 20, 2006
Human CD4+CD25high regulatory T cells modulate myeloid but not plasmacytoid dendritic cells activationRoch Houot, Ivan Perrot, Eric Garcia, et al.
British Journal of Haematology|May 5, 2023
Obinutuzumab-induced acute thrombocytopenia: Report of two cases and review of literatureYaquine Mechelfekh, Audrey Pontrucher, Jérôme Paillassa, et al.
European Journal of Cancer (Oxford, England : 1990)|March 20, 2021
SARS-CoV-2 vaccines for cancer patients treated with immunotherapies: Recommendations from the French society for ImmunoTherapy of Cancer (FITC)Marie-Léa Gauci, Clélia Coutzac, Roch Houot, et al.
Pageof 24

Showing results (31-40 of 233) with videos related to

Sort By:
Pageof 24
Trends in Immunology|September 13, 2011
Targeting immune effector cells to promote antibody-induced cytotoxicity in cancer immunotherapyRoch Houot, Holbrook E Kohrt, Aurélien Marabelle, et al.
Current Opinion in Immunology|January 11, 2015
Dual antibody therapy to harness the innate anti-tumor immune response to enhance antibody targeting of tumorsCariad Chester, Aurelien Marabelle, Roch Houot, et al.
Cancer Journal (Sudbury, Mass.)|June 5, 2020
Immune and Cell Therapy in Non-Hodgkin LymphomaReid W Merryman, Roch Houot, Philippe Armand, et al.
Hemasphere|May 1, 2026
In vivo CAR therapies: Turning the patient into their own CAR factoryFrançois Vilcot, Carole-Anne Brugère, Jaime Fuentealba, et al.
Dermatology (Basel, Switzerland)|October 13, 2006
Aggressive CD30 large cell lymphoma after cyclosporine given for putative atopic dermatitisFanny Mougel, Stéphane Dalle, Brigitte Balme, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2024
Cancer immunotherapy in elderly patients: The concept of immune senescence challenged by clinical experienceMathilde Guégan, Malvina Bichon, Nathalie Chaput, et al.
European Journal of Cancer (Oxford, England : 1990)|September 27, 2022
Transplant-ineligible but chimeric antigen receptor T-cells eligible: a real and relevant populationSamuel Vic, Jean Lemoine, Philippe Armand, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 20, 2006
Human CD4+CD25high regulatory T cells modulate myeloid but not plasmacytoid dendritic cells activationRoch Houot, Ivan Perrot, Eric Garcia, et al.
British Journal of Haematology|May 5, 2023
Obinutuzumab-induced acute thrombocytopenia: Report of two cases and review of literatureYaquine Mechelfekh, Audrey Pontrucher, Jérôme Paillassa, et al.
European Journal of Cancer (Oxford, England : 1990)|March 20, 2021
SARS-CoV-2 vaccines for cancer patients treated with immunotherapies: Recommendations from the French society for ImmunoTherapy of Cancer (FITC)Marie-Léa Gauci, Clélia Coutzac, Roch Houot, et al.
Pageof 24